Lyra Therapeutics Inc LYRA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:27 AM EDT
0.35quote price arrow down-0.004 (-1.1255%)
Volume
25,738
Close
0.3554quote price arrow down-0.0176 (-4.7185%)
Volume
4,715,621
52 week range
0.34 - 6.79
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3554
  • 52 Week High6.79
  • 52 Week High Date03/27/24
  • 52 Week Low0.34
  • 52 Week Low Date05/21/24

Key Stats

  • Market Cap21.667M
  • Shares Out60.96M
  • 10 Day Average Volume5.58M
  • Dividend-
  • Dividend Yield-
  • Beta-0.02
  • YTD % Change-93.22

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3554
  • 52 Week High6.79
  • 52 Week High Date03/27/24
  • 52 Week Low0.34
  • 52 Week Low Date05/21/24
  • Market Cap21.667M
  • Shares Out60.96M
  • 10 Day Average Volume5.58M
  • Dividend-
  • Dividend Yield-
  • Beta-0.02
  • YTD % Change-93.22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.23
  • P/E (TTM)-0.29
  • Fwd P/E (NTM)-0.32
  • EBITDA (TTM)-71.594M
  • ROE (TTM)-95.93%
  • Revenue (TTM)1.68M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,099.82%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lyra Therapeutics Inc

 

Profile

MORE
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are...
Harlan Waksal M.D.
Executive Chairman of the Board
Maria Palasis Ph.D.
President, Chief Executive Officer, Director
Jason Cavalier
Chief Financial Officer, Treasurer, Secretary
John Bishop Ph.D.
Chief Technology Officer
Address
480 Arsenal Way
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
SLGL
Sol Gel Technologies Ltd
0.7997+0.0947+13.4326%
CYTH
Cyclo Therapeutics Inc
1.36-0.06-4.23%
LUMO
Lumos Pharma Inc
2.52-0.10-3.82%
ONCT
Oncternal Therapeutics Inc
8.61+0.01+0.12%
FEMY
Femasys Inc
1.28+0.02+1.59%